Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07385950
Eligibility Criteria:
Inclusion Criteria:
1. Voluntarily provide written informed consent.
2. Age ≥ 18 years.
3. Newly diagnosed with a clinically/radiologically suspected or pathologically confirmed malignant solid tumor, or with suspected recurrence after prior treatment.
4. Eastern Cooperative Oncology Group Performance Status (ECOG PS) score of 0 or 1.
5. Life expectancy \> 6 months.
6. Participants of childbearing potential and their partners must agree to use highly effective contraception for 6 months following the last dose of the investigational agent.
Exclusion Criteria:
1. Prior radioisotope therapy within an interval less than 10 times the physical half-life of the respective radionuclide before study administration.
2. Concurrent participation in any other interventional clinical trial.
3. Known allergy or hypersensitivity to the investigational agent or any of its excipients.
4. Inability to lie still for the duration of the PET scan or any condition contraindicating PET imaging.
5. Pregnancy or lactation.
6. Any other condition that, in the investigator's judgment, would compromise participant safety or study integrity.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT07385950
Study Brief:
Protocol Section:
NCT07385950